VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RGENRepligen Corporation
$147.01$8.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksRGENBalance Sheet

Repligen Corporation (RGEN) Balance Sheet

30Y historyFree accessUpdated daily

The company maintains a disciplined capital structure with a stable debt-to-equity ratio of 0.33 and a significant liquidity buffer reflected in a 9.20 current ratio as of 2026Q1.

RGEN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01Mar'00Mar'99Mar'98Mar'97Mar'96
Total Current Assets1.16B1.14B1.07B1.11B998.12M931.68M902.38M641.83M275.74M242.78M184.15M103.25M80.95M86.35M66.21M55.84M59.68M54.78M54.42M25.73M21.51M18.87M16.13M13.82M23.24M25.65M35.67M4.5M5M5.9M4.7M
Cash & Short-Term Investments784.53M767.63M757.36M751.32M623.76M603.81M717.29M528.39M193.82M173.76M141.78M73.41M62M61.62M40.06M49.63M53.13M48.86M49.78M22.63M18.88M17.21M13.95M11.55M20.84M23.94M34.03M3.3M3.7M4.9M3.3M
Cash Only582.65M566.02M757.36M751.32M523.46M603.81M717.29M528.39M193.82M173.76M141.78M73.41M62M39.83M29.21M14.2M12.53M5.04M32.56M7.73M5.43M3.22M3.96M2.37M8.7M16.16M25.23M3.3M3.7M4.9M3.3M
Short-Term Investments201.88M201.61M00100.3M0000000021.79M10.85M35.42M40.61M43.82M17.22M14.9M13.45M13.99M10M9.18M12.14M7.77M8.81M0000
Accounts Receivable151.55M158.59M134.12M124.16M116.25M117.42M71.39M43.67M35.75M27.74M16.03M11.45M8M11.89M13.43M3.77M3.88M2.87M2.58M1.55M1.31M593.73K764.23K789.82K907.5K865.86K812.48K400K300K400K700K
Days Sales Outstanding73.6478.4177.1671.6752.9463.9271.1458.9867.2671.6855.9850.0145.9563.6778.7250.4567.4635.6348.7640.1637.0723.1540.3437.0977134.6785.9456.1545.6338.4223.44
Inventory179.26M170.46M142.96M202.32M238.28M184.49M95.03M54.83M42.26M39M24.7M18M12.38M11.8M11.14M1.95M2.2M2.41M2.8M1.51M1.47M633.31K879.38K1.01M916.09K634.72K547.45K600K700K500K400K
Days Inventory Outstanding213.97159.27145.03208.65251.49241.12201.76151.6179.47212.33191.31186.36161.3171.14149.7100.2145.91129.98166.15152.93150.6559.4698.81106.32167.8206.3255.45547.5851.67608.331.46K
Other Current Assets46.02M27.14M20.6M19.92M17.41M19.27M14.09M12.13M2.43M1.38M662K917K1.01M557.11K1.22M552.18K114.69K00146.83K153.56K000000241.65K300K100K300K
Total Non-Current Assets1.77B1.81B1.76B1.72B1.53B1.43B1B758.28M498.88M500.74M104.76M42.98M47.35M32.29M30.8M16.45M16.45M11.74M18.97M14.42M3.34M7.09M8.74M19.33M8.95M5.87M6.49M617.63K700K800K1M
Property, Plant & Equipment287.11M306.15M333.12M322.95M315.7M226.52M92.05M74.16M32.18M22.42M14.96M13.8M14.53M12.51M9.95M2.16M3.13M3.67M3.41M3.14M2.36M1.91M2.18M2.28M1.46M444.12K536.25K600K600K700K800K
Fixed Asset Turnover2.49x2.41x1.90x1.96x2.54x2.96x3.98x3.64x6.03x6.30x6.99x6.05x4.37x5.45x6.26x12.66x6.69x8.00x5.65x4.48x5.48x4.91x3.17x3.40x2.95x5.28x6.43x4.33x4.00x5.43x13.63x
Goodwill1.11B1.11B1.03B987.12M855.51M860.36M618.3M468.41M326.74M327.33M59.55M14.35M14.18M994K994K994K994K994M0000000000000
Intangible Assets368.19M386.15M397.9M406.96M360.62M337.27M287.1M212.55M135.44M144.75M29.81M12.76M14.64M6.19M7.18M1.22M1.22M1.4M0000000000000
Long-Term Investments1.99M000000000450K1.63M3.55M12.22M9.91M11.88M6.01M15.1M10.81B10.81B4.53B6.63B6.63B00000000
Other Non-Current Assets3.89M4.91M868K1.28M815K615K573K238K174K6.23M450K450K450K200K200K200K200K200K200K11.01M200K4.73M6.83M17.05M6.7M4.41M6.05M81.38K100K100K200K
Total Assets2.93B2.95B2.83B2.83B2.53B2.36B1.9B1.4B139.45M120.41M288.91M146.24M-65.43M118.64M97.01M72.29M71.42M73.75M68.84M29.08M28.6M27.61M29.61M33.15M29.11M32.15M36.29M5.2M5.7M6.7M5.7M
Asset Turnover0.26x0.25x0.22x0.22x0.32x0.28x0.19x0.19x1.39x1.17x0.36x0.57x-0.57x0.64x0.38x0.29x0.40x0.28x0.48x0.45x0.34x0.23x0.23x0.15x0.07x0.10x0.50x0.42x0.57x1.91x
Asset Growth %11.67%4.24%-0.05%11.83%7.35%23.94%35.91%904.03%15.81%-58.32%97.56%323.52%-155.14%22.3%34.19%1.22%-3.17%7.14%136.76%1.67%3.59%-6.78%-10.66%13.87%-9.45%-11.41%597.84%-8.77%-14.93%17.54%-68.51%
Total Current Liabilities126.21M135.83M126.79M164.94M404.2M375.26M318.96M48.31M129.84M25.21M21.07M18.78M10.68M11.3M10.75M4.62M4.66M4.55M4.59M3.34M2.94M3.2M2.45M2.81M2.67M1.26M1.2M600K400K300K800K
Accounts Payable34.66M30.01M32.13M19.56M27.55M36.2M16.88M11.43M10.49M7.28M5.06M6.72M3.86M1.72M2.45M1.42M930.6K991K1.92M2.72M1.16M1.07M1.02M735.58K968.55K1.41M529.91K425.56K100K100K300K
Days Payables Outstanding38.4728.0432.620.1829.0847.3135.8431.5944.5439.6439.2169.6250.3224.9732.9772.9561.6953.38113.91274.84119.39100.12114.2777.14177.41457.62247.26388.33121.67121.671.09K
Short-Term Debt21.07M21.56M069.45M284.62M255.26M243.74M0103.49M0000000000000000000000
Deferred Revenue (Current)69.4M14.61M13.24M17.07M19.28M14.68M15.32M5M1.29M960K408K258K130K3.34K599.12K0660.62K000127.17K38.6K000000000
Other Current Liabilities25M25.91M49.29M29.64M47.47M42.15M20.29M19.85M9.95M9.56M5.59M4.68M3.76M3.17M3.63M3.69M1.47M000309.01K1.77M00000771.52K300K200K500K
Current Ratio9.20x8.37x8.41x6.74x2.47x2.48x2.83x13.28x2.12x9.63x8.74x5.50x7.58x7.64x6.16x12.08x12.81x12.04x11.86x7.71x7.33x5.90x6.58x4.92x8.72x20.41x29.80x7.50x12.50x19.67x5.88x
Quick Ratio7.78x7.12x7.28x5.51x1.88x1.99x2.53x12.15x1.80x8.08x7.57x4.54x6.42x6.60x5.12x11.66x12.34x11.51x11.25x7.26x6.83x5.70x6.22x4.56x8.37x19.91x29.34x6.50x10.75x18.00x5.38x
Cash Conversion Cycle249.14209.64189.59260.14275.34257.72237.07178.99202.18244.37208.08166.74156.93209.84195.4677.71151.68112.23101-81.7568.32-17.5124.8866.2767.4-116.6494.12215.33775.63525.09388.44
Total Non-Current Liabilities699.1M707.74M730.16M701.4M216.7M233.03M54.78M292.03M29.21M126.76M99.07M4.71M5.88M3.46M2.13M584.16K584.16K642.45K82.4K143.04K200.34K230.52K119.89K00000000
Long-Term Debt546.59M542.21M525.57M510.14M000232.77M099.25M95.27M00000000000119.89K00000000
Capital Lease Obligations514.06M126.18M145.58M126.58M131.39M102.49M26.43M27M00000000000000000000000
Deferred Tax Liabilities80.97M22.5M22.77M39.32M23M33.48M27.03M29.94M25.09M25.17M000184.85M2.56B0000000000000000
Other Non-Current Liabilities17.53M15.32M36.24M25.35M62.31M97.05M1.32M2.33M4.13M2.34M3.8M4.71M5.88M3.46M2.13M584.16K642.45K82.4K143.04K200.34K230.52K0000000000
Total Liabilities825.31M843.57M856.95M866.34M620.9M608.29M373.74M340.35M159.05M151.97M120.15M23.49M16.56M14.76M12.89M5.21M5.21M5.3M4.63M4.73M3.54M3.17M3.32M2.81M2.24M2.67M1.26M1.2M400K300K800K
Total Debt687.62M689.95M686.25M711.8M422.96M366.05M275.42M263.32M103.49M99.25M95.27M00000000000119.89K00000000
Net Debt104.97M123.93M-71.11M-39.52M-100.5M-237.76M-441.88M-265.07M-90.33M-74.51M-46.51M-73.41M-62M-39.83M-29.21M-14.2M-12.53M-5.04M-32.56M-7.73M-5.43M-3.1M-3.96M-2.37M-8.7M-16.16M-25.23M-3.3M-3.7M-4.9M-3.3M
Debt / Equity0.33x0.33x0.35x0.36x0.22x0.21x0.18x0.25x0.17x0.17x0.56x-----------0.00x--------
Debt / EBITDA4.42x4.99x13.34x5.32x1.50x1.78x2.54x4.32x2.48x4.06x4.47x--------------------
Net Debt / EBITDA0.68x0.90x-1.38x-0.30x-0.36x-1.16x-4.08x-4.35x-2.16x-3.05x-2.18x-4.00x-4.21x-1.53x-2.00x-10.92x--1.02x-0.89x------------
Interest Coverage2.64x3.69x-0.28x5.91x74.00x12.96x5.88x3.81x3.87x2.13x5.10x420.47x222.96x461.67x199.74x-65.16x-8.79x-1652.59x1949.27x--2.62x----------
Total Equity2.11B2.11B1.97B1.96B1.91B1.75B1.53B1.06B615.57M591.55M168.76M122.75M111.73M103.89M84.12M67.09M67.09M66.12M69.12M64.11M25.54M25.43M24.29M30.34M24.55M26.44M30.89M35.09M5.3M6.4M4.9M
Equity Growth %19.89%6.76%0.4%2.83%9.18%14.45%44.29%72.16%4.06%250.52%37.49%9.86%7.55%23.49%25.4%0%1.46%-4.34%7.83%151.02%0.41%4.71%-19.95%23.6%-7.17%-14.39%-11.97%562.08%-17.19%30.61%-51.49%
Book Value per Share37.1637.2435.2734.8533.2630.5628.3721.5413.5415.114.953.663.363.212.692.182.182.112.212.110.830.850.821.130.921.001.431.950.320.380.32
Total Shareholders' Equity2.11B2.11B1.97B1.96B1.91B1.75B1.53B1.06B615.57M591.55M168.76M122.75M111.73M103.89M84.12M67.09M67.09M66.12M69.12M64.11M25.54M25.43M24.29M30.34M24.55M26.44M30.89M35.09M5.3M6.4M4.9M
Common Stock564K563K561K558K556K553K548K521K439K436K338K329K327.74K319.26K311.95K308.12K307.62K307.42K310.73K304.78K303.78K300.94K300.36K299.38K266.43K266.29K263.16K0000
Retained Earnings464.58M456.25M407.35M432.87M397.27M194.06M65.77M5.84M-15.57M-31.51M-59.86M-71.54M-80.89M-89.06M-105.15M-117.96M-117.92M-113.86M-120.58M-157.68M-156.79M-157.49M-154.51M-151.25M-140.42M-135.96M-130.68M-126.9M-125.2M-124M-123.4M
Treasury Stock0000000000000000000000000000000
Accumulated OCI-14.31M-2.53M-52.53M-37.81M-34.39M-16.89M2.08M-15.03M-11.89M-6.36M-13.75M-8.57M-5.77M2M1.91M-6.79M-5.47M-4.22M-3.42M-2.61M-61.95K-1.77M-23.6K-39.02K-1.72M-1.46M-1.19M-900K-800K-500K-300K
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Acquisition-driven goodwill impairment risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Capital Structure Stability Amid Normalization

According to recent quarterly filings, Repligen has maintained a consistent total asset base of approximately $2.9 billion since 2025Q1, suggesting that the company has successfully stabilized its balance sheet following the volatile post-pandemic period and is now operating from a more predictable capital foundation.

The stability in total assets despite significant fluctuations in cash and working capital indicates that the firm's core productive capacity remains intact. Investors should monitor whether this plateau in asset growth reflects a strategic pause in M&A activity or a temporary limitation in finding accretive targets at current valuations.

Robust Liquidity Buffers Against Volatility

Based on reported financial statements, Repligen’s current ratio has improved significantly to 9.20 in 2026Q1 from a low of 6.35 in 2024Q1, providing a substantial liquidity cushion that appears more than adequate to cover near-term operational requirements and potential supply chain disruptions.

This high current ratio suggests a conservative approach to working capital management, though it may also imply an inefficient use of cash that could otherwise be deployed for growth. The significant liquidity buffer provides management with flexibility to navigate ongoing industry destocking cycles without needing to access external capital markets.

Intangible Concentration in Asset Mix

As indicated by the latest balance sheet data, goodwill has risen to $1.1 billion as of 2026Q1, representing a significant portion of the $2.9 billion total asset base, which warrants close scrutiny regarding the long-term carrying value of past acquisitions in a shifting bioprocessing landscape.

The heavy reliance on intangible assets suggests that the company's competitive position is deeply tied to the success of its acquired technologies rather than physical infrastructure. If the anticipated synergies from these acquisitions fail to materialize in the current margin-constrained environment, the firm may face future impairment risks that could impact book value.

Strategic Leverage Remains Well Controlled

According to the company's reported figures, the debt-to-equity ratio has remained remarkably stable at 0.33 throughout the most recent four quarters, demonstrating a disciplined approach to leverage that keeps the firm's financial risk profile well within manageable bounds for a company of its size.

The consistent D/E ratio suggests that management is not relying on aggressive debt financing to fund its operations or acquisitions, which is a positive signal for long-term solvency. This moderate leverage profile provides the company with the capacity to take on additional debt if a strategic opportunity arises, provided that cash flow generation continues to improve.

RGEN — Frequently Asked Questions

Quick answers to the most common questions about buying RGEN stock.

What are the total assets of Repligen Corporation (RGEN)?

As of 2025, Repligen Corporation (RGEN) had total assets of $2.95B including $1.14B in current assets.

How much debt does Repligen Corporation (RGEN) have?

Repligen Corporation (RGEN) carries total debt of $689.9M, offset by $767.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Repligen Corporation?

Repligen Corporation (RGEN) has total shareholders' equity (book value) of $2.11B ($37.24 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Repligen Corporation's current ratio and liquidity?

Repligen Corporation (RGEN) reported a current ratio of 8.37x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.